Different Infection Risks for MS Treatments

October 14, 2019 0

The risk of serious infections is higher for patients with multiple sclerosis (MS) taking rituximab than for those on natalizumab or fingolimod, and this increased risk is even more pronounced when compared Read More

1 2 3 5